| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1051283139 |
| P356 | DOI | 10.1038/LABINVEST.3700223 |
| P698 | PubMed publication ID | 15592495 |
| P5875 | ResearchGate publication ID | 8134724 |
| P2093 | author name string | Eiwa Ishida | |
| Hiroyuki Nakase | |||
| Toshisuke Sakaki | |||
| Keiji Shimada | |||
| Mitsutoshi Nakamura | |||
| Noboru Konishi | |||
| Munehiro Kishi | |||
| P2860 | cites work | A third member of the synapsin gene family | Q24323990 |
| Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
| Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas | Q24671002 | ||
| The DNA sequence of human chromosome 22 | Q28139873 | ||
| A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 | Q28185858 | ||
| Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer | Q28277002 | ||
| Matrix metalloproteinases: a review | Q29620220 | ||
| Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. | Q34082589 | ||
| Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). | Q39600883 | ||
| Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene | Q43750899 | ||
| Quantitative real-time PCR identifies a critical region of deletion on 22q13 related to prognosis in oral cancer. | Q44134120 | ||
| Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma | Q47277343 | ||
| PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas | Q47740646 | ||
| Exon scanning for mutation of the NF2 gene in schwannomas | Q48084702 | ||
| Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade. | Q48136945 | ||
| Subsets of glioblastoma multiforme defined by molecular genetic analysis | Q48379049 | ||
| p14ARF deletion and methylation in genetic pathways to glioblastomas. | Q48916439 | ||
| Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas | Q48972634 | ||
| Promoter hypermethylation of the RB1 gene in glioblastomas. | Q55474611 | ||
| Loss of heterozygosity on chromosome 19 in secondary glioblastomas. | Q55475568 | ||
| Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas. | Q55476215 | ||
| Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. | Q55481776 | ||
| Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations | Q55670910 | ||
| Expression and Prognostic Significance of Metalloproteinases and Their Tissue Inhibitors in Patients With Small-Cell Lung Cancer | Q57272687 | ||
| Mutations truncating the EP300 acetylase in human cancers | Q57888722 | ||
| A frequent deletion polymorphism on chromosome 22q13 identified by representational difference analysis of ovarian cancer | Q73134503 | ||
| Loss of heterozygosity at loci from chromosome arm 22Q in human sporadic breast carcinomas | Q74172507 | ||
| Mutational analysis of INI1 in sporadic human brain tumors | Q74310484 | ||
| Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions | Q78346047 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 165-175 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Laboratory Investigation | Q6467260 |
| P1476 | title | Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas. | |
| P478 | volume | 85 |
| Q30426125 | Advances in the genetics of glioblastoma: are we reaching critical mass? |
| Q34645950 | DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas |
| Q34722434 | DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression. |
| Q49123106 | Differential expression of a novel voltage gated potassium channel--Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma |
| Q55463980 | Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGH. |
| Q37127375 | Epigenetic contributions to cancer metastasis |
| Q37301207 | Epigenetic markers in human gliomas: prospects for therapeutic intervention |
| Q42514586 | Expression of angiogenic growth factor in the rat DAVF model |
| Q38526479 | Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas |
| Q46923958 | Genetic aberrations in tissue inhibitor of metalloproteinases-3 lead to manifestations of the myofibroblast phenotype in mouse fibroblasts and fibroblasts of patients with Sorsby fundus dystrophy |
| Q35757144 | Genetic pathways to primary and secondary glioblastoma |
| Q37858440 | Genetic profile of astrocytic and oligodendroglial gliomas |
| Q34794665 | Genomic changes in progression of low-grade gliomas |
| Q24656269 | IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas |
| Q53082211 | IL-32 gamma reduces lung tumor development through upregulation of TIMP-3 overexpression and hypomethylation. |
| Q38484441 | Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma |
| Q37004664 | Inhibition of angiogenesis and invasion in malignant gliomas |
| Q36075869 | Lack of Correlation between Aberrant p16, RAR-β2, TIMP3, ERCC1, and BRCA1 Protein Expression and Promoter Methylation in Squamous Cell Carcinoma Accompanying Candida albicans-Induced Inflammation |
| Q48698211 | Loss of 22q chromosome is related to glioma progression and loss of 10q. |
| Q37883145 | Loss of heterozygosity analysis in malignant gliomas. |
| Q35145251 | Molecular biological determinations of meningioma progression and recurrence |
| Q35799973 | Molecular pathogenesis of pediatric astrocytic tumors |
| Q35858003 | P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3. |
| Q38089921 | Prognostic markers of astrocytoma: how to predict the unpredictable? |
| Q33608536 | Progress in matrix metalloproteinase research |
| Q24632928 | Recent advances in the molecular understanding of glioblastoma |
| Q33736439 | Segmentation of genomic and transcriptomic microarrays data reveals major correlation between DNA copy number aberrations and gene-loci expression |
| Q88027699 | TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women |
| Q85864053 | TIMP3 controls cell fate to confer hepatocellular carcinoma resistance |
| Q39588375 | TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells. |
| Q38785433 | TIMPs: versatile extracellular regulators in cancer |
| Q37566195 | The role of HRK gene in human cancer |
| Q35217321 | Timp3 deficient mice show resistance to developing breast cancer |
| Q37937061 | Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets |
Search more.